Publikationen in Zusammenarbeit mit Forschern von Duke University (1)

2014

  1. Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

    Clinical Cancer Research, Vol. 20, Núm. 8, pp. 2092-2103